 Home > Active Ingredient News > Antitumor Therapy > WCLC 2022｜Can sintilimab combined with short-course chemotherapy regimens promote strengths and avoid weaknesses?

WCLC 2022｜Can sintilimab combined with short-course chemotherapy regimens promote strengths and avoid weaknesses?

 Last Update: 2022-08-20
 Source: Internet
 Author: User

Tags

what tissue cell

pressure cell

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

foreword

The 2022 International Association for the Study of Lung Cancer (IASLC) World Conference on Lung Cancer (WCLC) will be held in offline + online format from August 6 to 9, 2022

Research Introduction

Most advanced sq-NSCLC patients are older, have a history of heavy smoking, and have multiple comorbidities, and are considered to be poorly tolerant to chemotherapy

Research methods

Eligible patients received sintilimab (200 mg, IV) in combination with nab-paclitaxel and carboplatin (D1, Q3W) for 2 cycles

Research result

A total of 44 patients were enrolled for treatment from May 2020 to February 2022

Figure 1 PFS

At data cutoff, 36 patients (81.

Table 1 Adverse events

Analysis conclusion

As a first-line treatment for advanced sq-NSCLC, sintilimab combined with two cycles of nab-paclitaxel/carboplatin showed encouraging PFS and manageable safety profile

references:

EP08.

Editor: Jiang Zhou Typesetting: Jiang Zhou Execution: Uni

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

Crocetin27876-94-4

CAS No.: 27876-94-4

$1-1.1/G FOB

Betulinic acid472-15-1

CAS No.: 472-15-1

$1-1.1/G FOB

1-(2-chlorophenyl)-1-(4-chlorophenyl)-2,2-dichloroethane 53-19-0

CAS No.: 53-19-0

Pharmacy Grade

$100/KG EXW

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.